BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30006812)

  • 1. The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis.
    Yazdani J; Ghavimi MA; Jabbari Hagh E; Ahmadpour F
    Mol Diagn Ther; 2018 Oct; 22(5):523-535. PubMed ID: 30006812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis.
    Zhao Z; Ge J; Sun Y; Tian L; Lu J; Liu M; Zhao Y
    Oral Oncol; 2012 Sep; 48(9):761-7. PubMed ID: 22455948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
    Zhou LQ; Hu Y; Xiao HJ
    BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
    Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
    Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    Jamali Z; Asl Aminabadi N; Attaran R; Pournagiazar F; Ghertasi Oskouei S; Ahmadpour F
    Oral Oncol; 2015 Apr; 51(4):321-31. PubMed ID: 25677760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
    J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis.
    Cho JK; Lee GJ; Kim HD; Moon UY; Kim MJ; Kim S; Baek KH; Jeong HS
    PLoS One; 2018; 13(9):e0203758. PubMed ID: 30192876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Hasnat S; Hujanen R; Nwaru BI; Salo T; Salem A
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta-analysis.
    Wang P; Xu L; Li L; Ren S; Tang J; Zhang M; Xu M
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):957-968. PubMed ID: 30747316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
    Dong Y; Ma G; Liu Y; Lu S; Liu L
    Dis Markers; 2020; 2020():8842795. PubMed ID: 33062071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
    Xing L; Zhang X; Guo M; Zhang X; Liu F
    DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of modified Glasgow prognostic score for head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Luan CW; Kuo LT; Wang YT; Liao CT; Kang CJ; Lee YC; Chen KY; Lai CH; Tsai YH; Huang EI; Tsai MS; Hsu CM; Chang GH; Tsai YT
    Head Neck; 2023 Jul; 45(7):1856-1867. PubMed ID: 37161915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
    Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
    Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis.
    Dioguardi M; Spirito F; Sovereto D; Alovisi M; Aiuto R; Garcovich D; Crincoli V; Laino L; Cazzolla AP; Caloro GA; Di Cosola M; Ballini A; Lo Muzio L; Troiano G
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.
    Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis.
    Kang JW; Eun YG; Lee YC
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.